Olpasiran
amgen
[]
ocean(a)-dose shows remarkable lowering of lp(a), over 90%, and with safety. outcomes trials are next! there are multiple therapeutic agents in this space. will be interesting to see what works best and how they effect cv outcomes. #aha22
Noninvasive cardiologist keeping up with the latest CV news.